SAPA-NE 2025 Antibody Workshop
Sat, Mar 29
|Lilly Seaport Innovation Center (15 Necco St, Boston, MA 02210)
Next generation Antibody Therapeutics: Engineering, Conjugation, and Translational Strategies
Event Time
Mar 29, 2025, 1:00 PM – 5:00 PM EDT
Lilly Seaport Innovation Center (15 Necco St, Boston, MA 02210)
About the Event
🔥[Agenda]🔥
Parking Information:
Necco Garage (10 Necco St, Boston, MA): $14 on weekends.
45 Binford St Parking (Channelside Lot): $10 with an online reservation via ParkWiz or SpotHero.
Explore the Cutting-Edge Advancements in Antibody Engineering, ADCs, and Radiopharmaceutical-Antibody Conjugates, along with Preclinical Strategies to Accelerate Development
Join us for this exclusive event where top experts in the antibody field will share insights into groundbreaking innovations and preclinical strategies to accelerate drug development. This is a must-attend session for biotech professionals, researchers, and industry leaders looking to stay ahead in the fast-evolving biologics landscape.
Key Highlights:
🌟 Latest advancements in therapeutic antibody engineering
🌟 Insights into Antibody Drug Conjugates (ADCs) development
🌟Breakthroughs in radiopharmaceuticals for targeted radiotherapy (TRP)
🌟 Cutting-edge preclinical models for accelerating Bi- & Multi-Specific and ADC drug discovery
Featured Speakers:
🔹 Dr. Huawei Qiu – Former SVP, Head of Biologics Discovery, GV20 Therapeutics
Speech Title: “Therapeutic Antibody Engineering and Applications”
🔹 Dr. Zhaohui Sunny Zhou – Faculty Fellow, Barnett Institute of Chemical and Biological Analysis; Professor, Department of Chemistry and Chemical Biology, Northeastern University
Speech Title: “Shed Light on Antibody Drug Conjugates (ADCs)”
🔹 Dr. John Chen – Head of Mammalian Protein Department, GenScript Biotech
Speech Title: “Next-Gen BsAb Manufacturing: How TurboCHO Ensures High Productivity & Streamlined Purification”
🔹 Dr. Long Li – Fellow of Pharmacology and Toxicology, Telix Pharmaceuticals
Speech Title: “Early Development of Radiopharmaceuticals for Targeted Radiotherapy (TRP)”
🔹 Dr. Qiurong Wang – Business Development Director, Biocytogen
Speech Title: “Accelerating Bi- & Multi-Specific and ADC Drug Discovery with Drug-Targeted Humanized Mouse Models”
🔹 Dr. Tingxu Chen – Business Development Manager, Kactus Bio
Speech Title: “Engineering Complex Antigens for the Biopharma Industry: Multipass Transmembrane Proteins”
🚀 Don’t miss this opportunity to engage with leading experts, gain actionable insights, and network with biotech professionals shaping the future of biologics!
🔗 Register NOW and stay at the forefront of antibody innovation! Please email info@sapa-neweb.org if you have questions.